Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 2 (2005), Issue 7 (July)

1. Symptomatic metastases to the pituitary infundibulum resulting from primary breast cancer.
   Int J Clin Oncol, 10(3): 191-4. [Abstract] [Full-text]
2. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
   Int J Radiat Oncol Biol Phys, 62(4): 1133-9. [Abstract] [Full-text]
3. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
   Int J Radiat Oncol Biol Phys, 62(4): 1125-32. [Abstract] [Full-text]
4. Primary leptomeningeal gliomatosis: case report and review of the literature.
   Neurol Sci, 26(2): 129-34. [Abstract] [Full-text]
5. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
   Cancer Res, 65(13): 5683-9. [Abstract] [Full-text]
6. Lyn kinase activity is the predominant cellular SRC kinase activity in glioblastoma tumor cells.
   Cancer Res, 65(13): 5535-43. [Abstract] [Full-text]
7. Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
   Cancer Res, 65(13): 5523-34. [Abstract] [Full-text]
8. Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
   Eur J Endocrinol, 153(1): 143-51. [Abstract] [Full-text]
9. Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy.
   Eur J Endocrinol, 153(1): 135-41. [Abstract] [Full-text]
10. Papillary endothelial hyperplasia (Masson tumor) of the petrous and jugulare region: case report and literature review.
    Surg Neurol, 64(1): 55-60; discussion 60. [Abstract] [Full-text]
11. Functional magnetic resonance imaging-guided resection of low-grade gliomas.
    Surg Neurol, 64(1): 20-7; discussion 27. [Abstract] [Full-text]
12. Radiotherapy of localised intracranial germinoma: time to sever historical ties?
    Lancet Oncol, 6(7): 509-19. [Abstract] [Full-text]
13. Twin and triple peaks papilledema.
    Ophthalmology, 112(7): 1299-301. [Abstract] [Full-text]
14. Intracerebral schwannoma clinically and radiologically mimicking meningioma.
    Pathol Int, 55(8): 514-9. [Abstract] [Full-text]
15. mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete.
    Br J Cancer, 93(1): 152-8. [Abstract] [Full-text]
16. Mutations in Rb1 pathway-related genes are associated with poor prognosis in anaplastic astrocytomas.
    Br J Cancer, 93(1): 124-30. [Abstract] [Full-text]
17. Epigenetic mechanisms of tumorigenesis.
    Horm Metab Res, 37(6): 361-8. [Abstract] [Full-text]
18. Clinical and genetic features of familial pituitary adenomas.
    Horm Metab Res, 37(6): 347-54. [Abstract] [Full-text]
19. A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly.
    J Clin Endocrinol Metab, 90(7): 4405-10. [Abstract] [Full-text]
20. Endoscopic transnasal transsphenoidal pituitary surgery--comparison with the traditional sublabial transseptal approach.
    Otolaryngol Clin North Am, 38(4): 723-35. [Abstract] [Full-text]
21. NeuN expression correlates with reduced mitotic index of neoplastic cells in central neurocytomas.
    Neuropathol Appl Neurobiol, 31(4): 429-38. [Abstract] [Full-text]
22. Survivin is a negative prognostic marker in medulloblastoma.
    Neuropathol Appl Neurobiol, 31(4): 422-8. [Abstract] [Full-text]
23. Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative-PCR analysis of non-homogeneous gene amplification and DNA sequence alterations.
    Neuropathol Appl Neurobiol, 31(4): 384-94. [Abstract] [Full-text]
24. Third ventricular chordoid glioma: clinicopathological study of two cases with evidence for a poor clinical outcome despite low grade histological features.
    Neuropathol Appl Neurobiol, 31(4): 354-61. [Abstract] [Full-text]
25. Identification of consistent novel submegabase deletions in low-grade oligodendrogliomas using array-based comparative genomic hybridization.
    Genes Chromosomes Cancer, 44(1): 85-96. [Abstract] [Full-text]
26. Stereotactic radiosurgery followed by whole ventricular irradiation for primary intracranial germinoma of the pineal region.
    Minim Invasive Neurosurg, 48(3): 186-90. [Abstract] [Full-text]
27. Minimally invasive approach to management of pituitary adenomas.
    Minim Invasive Neurosurg, 48(3): 169-74. [Abstract] [Full-text]
28. Gliosarcoma cell death after radiosurgery in a rat model.
    Minim Invasive Neurosurg, 48(3): 142-8. [Abstract] [Full-text]
29. alpha(v)beta(3) Integrin in central nervous system tumors.
    Hum Pathol, 36(6): 665-9. [Abstract] [Full-text]
30. High resolution susceptibility weighted MR-imaging of brain tumors during the application of a gaseous agent.
    Rofo, 177(8): 1065-9. [Abstract] [Full-text]
31. Mobile phones, mobile phone base stations and cancer: a review.
    Int J Radiat Biol, 81(3): 189-203. [Abstract] [Full-text]
32. Plasma cell tumors in HIV-positive patients: report of a case and review of the literature.
    Leuk Lymphoma, 46(7): 1067-74. [Abstract] [Full-text]
33. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
    Gynecol Endocrinol, 20(6): 317-21. [Abstract] [Full-text]
34. Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells.
    FEBS Lett, 579(18): 3965-9. [Abstract] [Full-text]
35. Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome.
    J Neurol Neurosurg Psychiatry, 76(8): 1152-7. [Abstract] [Full-text]
36. Gorlin syndrome: the PTCH gene links ocular developmental defects and tumour formation.
    Br J Ophthalmol, 89(8): 988-91. [Abstract] [Full-text]
37. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme.
    Cancer Res, 65(14): 6459-65. [Abstract] [Full-text]
38. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Cancer Res, 65(14): 6178-88. [Abstract] [Full-text]
39. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
    Cancer Res, 65(14): 6029-33. [Abstract] [Full-text]
40. Anaplastic oligodendroglioma presenting with drop metastases in the cauda equina.
    Clin Neurol Neurosurg, 107(5): 417-20. [Abstract] [Full-text]
41. Non-invasive quantification of lactate by proton MR spectroscopy and its clinical applications.
    Clin Neurol Neurosurg, 107(5): 379-84. [Abstract] [Full-text]
42. Atypical presentations of solitary fibrous tumors of the central nervous system: an analysis of unusual clinicopathological and outcome patterns in three new cases with a review of the literature.
    Virchows Arch, 447(1): 81-6. [Abstract] [Full-text]
43. Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer.
    Cancer Gene Ther, 12(8): 708-14. [Abstract] [Full-text]
44. Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
    Eur J Cancer, 41(11): 1588-96. [Abstract] [Full-text]
45. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
    Australas Radiol, 49(4): 298-303. [Abstract] [Full-text]
46. Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations.
    Eur J Cancer, 41(11): 1597-603. [Abstract] [Full-text]
47. Neuregulin-1 enhances survival of human astrocytic glioma cells.
    Glia, 51(3): 217-28. [Abstract] [Full-text]
48. Ependymal tumors in childhood.
    Pediatr Blood Cancer, 45(3): 298-303. [Abstract] [Full-text]
49. Robotically guided radiosurgery for children.
    Pediatr Blood Cancer, 45(3): 304-10. [Abstract] [Full-text]
50. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis.
    Cancer Epidemiol Biomarkers Prev, 14(7): 1784-90. [Abstract] [Full-text]
51. Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.
    Int J Radiat Oncol Biol Phys, 62(5): 1423-6. [Abstract] [Full-text]
52. The clinical characteristics of headache in patients with pituitary tumours.
    Brain, 128: 1921-30. [Abstract] [Full-text]
53. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
    J Clin Oncol, 23(21): 4726-34. [Abstract] [Full-text]
54. Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity.
    Lancet Neurol, 4(8): 476-86. [Abstract] [Full-text]
55. Effects of medical therapy on pituitary tumors.
    Ultrastruct Pathol, 29(3): 163-7. [Abstract] [Full-text]
56. The C3435T polymorphism of MDR1 and susceptibility to adult glioma.
    Neuroepidemiology, 25(2): 85-90. [Abstract] [Full-text]
57. White matter anisotropy in childhood medulloblastoma survivors: association with neurotoxicity risk factors.
    Radiology, 236(2): 647-52. [Abstract] [Full-text]
58. Applications of mouse glioma models in preclinical trials.
    Mutat Res, 576(1): 54-65. [Abstract] [Full-text]
59. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.
    Cancer Treat Rev, 31(4): 256-73. [Abstract] [Full-text]
60. Brain metastasis of unknown primary: a diagnostic and therapeutic dilemma.
    Cancer Treat Rev, 31(4): 247-55. [Abstract] [Full-text]
61. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
    Strahlenther Onkol, 181(8): 507-14. [Abstract] [Full-text]
62. 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomas.
    Strahlenther Onkol, 181(8): 500-6. [Abstract] [Full-text]
63. Mortality in US Army Gulf War veterans exposed to 1991 Khamisiyah chemical munitions destruction.
    Am J Public Health, 95(8): 1382-8. [Abstract] [Full-text]
64. Prospective assessment of patient-rated symptoms following whole brain radiotherapy for brain metastases.
    J Pain Symptom Manage, 30(1): 18-23. [Abstract] [Full-text]
65. Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in National Collaborative Research Studies (CCG 9891/POG 9130).
    J Clin Oncol, 23(22): 5198-204. [Abstract] [Full-text]
66. Intracranial capillary hemangioma: case report and review of the literature.
    Surg Neurol, 64(2): 154-9. [Abstract] [Full-text]
67. Preoperative evaluation of venous systems with 3-dimensional contrast-enhanced magnetic resonance venography in brain tumors: comparison with time-of-flight magnetic resonance venography and digital subtraction angiography.
    Surg Neurol, 64(2): 128-33; discussion 133-4. [Abstract] [Full-text]
68. Neurosurgical approach to treating pituitary adenomas.
    Growth Horm IGF Res, 15: S36-41. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.